Evidence map›Paper›PMID 23706681›Full record

SynthesisBiological psychiatry2013

Compared to what? Early brain overgrowth in autism and the perils of population norms.

Armin Raznahan, Gregory L Wallace, Ligia Antezana, Dede Greenstein, Rhoshel Lenroot, Audrey Thurm, Marta Gozzi, Sarah Spence, Alex Martin, Susan E Swedo and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in Biological psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. A meta-analytic investigation of grey matter differences in anorexia nervosa and autism spectrum disorder.European eating disorders review : the journal of the Eating Disorders Association · 2022
    Pooled it
  2. Autism spectrum disorder and schizophrenia: An updated conceptual review.Autism research : official journal of the International Society for Autism Research · 2022
    Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Article
  7. Article
  8. Molecular psychiatry · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Canada population norms for the EQ-5D-5L.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  13. Candidate biomarkers in psychiatric disorders: state of the field.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  14. Review
  15. Article
  16. Neuropsychiatric "Comorbidity" as Causal Influence in Autism.Journal of the American Academy of Child and Adolescent Psychiatry · 2020
    Review
  17. Review
  18. Article
  19. Autism spectrum disorder.Lancet (London, England) · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Armin RaznahanChild Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland. Electronic address: raznahana@mail.nih.gov.
Gregory L Wallace
Ligia Antezana
Dede Greenstein
Rhoshel Lenroot
Audrey Thurm
Marta Gozzi
Sarah Spence
Alex Martin
Susan E Swedo
Jay N Giedd

Funding

Clinical and Behavioral Phenotyping of Autism and Related DisordersZIAMH002868 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI SWEDO, SUSAN · 2009 to 2017
$17.8M
Pediatric Brain ImagingZIAMH002794 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI RAPOPORT, JUDITH L. · 2009 to 2015
$15.3M
The Cognitive Neuroscience of Autism Spectrum DisordersZIAMH002920 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MARTIN, ALEX · 2009 to 2025
$14.6M
Intramural NIH HHS Z99 MH999999
6 · The paper itself

Abstract

backgroundEarly brain overgrowth (EBO) in autism spectrum disorder (ASD) is among the best replicated biological associations in psychiatry. Most positive reports have compared head circumference (HC) in ASD (an excellent proxy for early brain size) with well-known reference norms. We sought to reappraise evidence for the EBO hypothesis given 1) the recent proliferation of longitudinal HC studies in ASD, and 2) emerging reports that several of the reference norms used to define EBO in ASD may be biased toward detecting HC overgrowth in contemporary samples of healthy children.

methodsSystematic review of all published HC studies in children with ASD. Comparison of 330 longitudinally gathered HC measures between birth and 18 months from male children with autism (n = 35) and typically developing control subjects (n = 22).

resultsIn systematic review, comparisons with locally recruited control subjects were significantly less likely to identify EBO in ASD than norm-based studies (p < .001). Through systematic review and analysis of new data, we replicate seminal reports of EBO in ASD relative to classical HC norms but show that this overgrowth relative to norms is mimicked by patterns of HC growth age in a large contemporary community-based sample of US children (n ~ 75,000). Controlling for known HC norm biases leaves inconsistent support for a subtle, later emerging and subgroup specific pattern of EBO in clinically ascertained ASD versus community control subjects.

conclusionsThe best-replicated aspects of EBO reflect generalizable HC norm biases rather than disease-specific biomarkers. The potential HC norm biases we detail are not specific to ASD research but apply throughout clinical and academic medicine.

Indexed as

Age FactorsAutistic DisorderBrainChild, PreschoolHeadHumansMalePopulationAutismbiasCDChead circumferencesystematic reviewWHO

Identifiers

PMID23706681
PMCPMC4837958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.